Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.2%

1 terminated out of 24 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed with results

Key Signals

3 with results93% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (10)
P 1 (1)
P 2 (3)
P 3 (2)

Trial Status

Completed13
Unknown4
Recruiting3
Active Not Recruiting2
Terminated1
Withdrawn1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT07549945Not ApplicableCompletedPrimary

Restricted Fluid Therapy for Newborn Breathing Problems

NCT07344714Recruiting

Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting

NCT06200519Active Not Recruiting

Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography

NCT03346343Not ApplicableActive Not Recruiting

Pulmonary Function Using Non-invasive Forced Oscillometry

NCT06803355Completed

Comparison of Congenital Pneumonia and Transient Tachypnea of the Newborn

NCT06278415Not ApplicableRecruitingPrimary

Physiologically Based Cord Clamping To Improve Neonatal Outcomes After Elective Cesarean Delivery

NCT06270823Not ApplicableRecruitingPrimary

Reducing Respiratory Distress After Elective Caesarean Birth Through Knee-chest-flexion: a Randomized Controlled Trial

NCT03006354Not ApplicableCompletedPrimary

nHFOV Versus nCPAP in Transient Tachypnea of the Newborn

NCT03499418WithdrawnPrimary

Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Neonates

NCT05538780UnknownPrimary

Diagnosis of Transient Tachypnea of Newborn

NCT05006235Phase 1CompletedPrimary

Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)

NCT04780412Phase 3UnknownPrimary

Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section

NCT04722016Completed

LUNG ULTRASONOGRAPHY DECREASES RADIATION EXPOSURE

NCT03165305Not ApplicableCompleted

The Role of Sustained Inflation on Short Term Respiratory Outcomes in Term Infants

NCT01310153Not ApplicableCompleted

Effect of Supine or Prone Position After Caesarean Birth

NCT03208894Phase 3CompletedPrimary

Role of Salbutamol and Furosemide in TTN

NCT01270581Not ApplicableTerminatedPrimary

High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation

NCT02965365CompletedPrimary

PATET Ratio to Rule Out Transient Tachypnea of the Newborn

NCT01517958CompletedPrimary

Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates

NCT01858129Phase 2UnknownPrimary

Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn

Scroll to load more

Research Network

Activity Timeline